Total Payments
$16,375
2024 Payments
$2,748
Companies
54
Transactions
714
Medicare Patients
3,672
Medicare Billing
$453,105
Payment Breakdown by Category
Food & Beverage$14,666 (89.6%)
Consulting$1,500 (9.2%)
Education$144.07 (0.9%)
Gifts$64.43 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,666 | 708 | 89.6% |
| Consulting Fee | $1,500 | 1 | 9.2% |
| Education | $144.07 | 4 | 0.9% |
| Gift | $64.43 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,898 | 214 | $0 (2024) |
| PENTAX of America, Inc. | $1,512 | 2 | $0 (2020) |
| Janssen Biotech, Inc. | $1,304 | 64 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,196 | 105 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,022 | 56 | $0 (2024) |
| Gilead Sciences, Inc. | $512.79 | 19 | $0 (2024) |
| GENZYME CORPORATION | $482.17 | 16 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $468.89 | 17 | $0 (2024) |
| Boston Scientific Corporation | $451.19 | 6 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $450.41 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,748 | 127 | ABBVIE INC. ($1,114) |
| 2023 | $2,847 | 135 | ABBVIE INC. ($1,221) |
| 2022 | $2,238 | 92 | ABBVIE INC. ($1,023) |
| 2021 | $1,440 | 59 | AbbVie Inc. ($851.93) |
| 2020 | $2,412 | 36 | PENTAX of America, Inc. ($1,512) |
| 2019 | $1,898 | 118 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($386.66) |
| 2018 | $1,599 | 102 | Takeda Pharmaceuticals U.S.A., Inc. ($407.65) |
| 2017 | $1,194 | 45 | Gilead Sciences Inc ($301.95) |
All Payment Transactions
714 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.20 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Gastroenterology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/26/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.64 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $112.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Immunology | ||||||
| 10/31/2024 | CapsoVision, Inc. | CapsoCam Plus (Device) | Food and Beverage | Cash or cash equivalent | $43.81 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,002 | 1,053 | $576,600 | $133,364 |
| 2022 | 14 | 1,052 | 1,096 | $585,220 | $132,573 |
| 2021 | 14 | 954 | 998 | $503,085 | $119,026 |
| 2020 | 14 | 664 | 689 | $323,255 | $68,143 |
Total Patients
3,672
Total Services
3,836
Medicare Billing
$453,105
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 241 | 241 | $86,760 | $32,196 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 206 | 250 | $56,250 | $25,733 | 45.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 76 | 76 | $95,000 | $15,680 | 16.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 142 | 145 | $110,400 | $10,940 | 9.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 101 | 101 | $89,100 | $10,147 | 11.4% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 11 | 11 | $12,100 | $7,764 | 64.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 37 | 38 | $19,000 | $7,259 | 38.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 24 | 24 | $12,000 | $4,567 | 38.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 51 | 51 | $12,750 | $4,553 | 35.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 30 | $9,000 | $3,342 | 37.1% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 11 | 12 | $7,440 | $3,141 | 42.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 23 | 24 | $22,800 | $3,000 | 13.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 30 | 30 | $12,000 | $2,881 | 24.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 19 | 20 | $32,000 | $2,160 | 6.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 259 | 259 | $93,240 | $35,358 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 174 | 209 | $47,025 | $22,992 | 48.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 108 | 108 | $100,705 | $13,447 | 13.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 61 | 61 | $76,250 | $12,713 | 16.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 141 | 141 | $104,800 | $10,640 | 10.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 77 | 77 | $23,100 | $8,683 | 37.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 34 | 34 | $17,000 | $6,712 | 39.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 44 | 46 | $18,400 | $4,239 | 23.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 21 | 21 | $10,500 | $4,051 | 38.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 26 | 26 | $24,700 | $3,971 | 16.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 34 | 34 | $54,400 | $3,607 | 6.6% |
About Dr. Paul Lee, MD
Dr. Paul Lee, MD is a Internal Medicine healthcare provider based in Irvine, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1760531693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Lee, MD has received a total of $16,375 in payments from pharmaceutical and medical device companies, with $2,748 received in 2024. These payments were reported across 714 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($14,666).
As a Medicare-enrolled provider, Lee has provided services to 3,672 Medicare beneficiaries, totaling 3,836 services with total Medicare billing of $453,105. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology, Hepatology
- Location Irvine, CA
- Active Since 01/09/2007
- Last Updated 10/29/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760531693
Products in Payments
- SKYRIZI (Biological) $1,580
- C.A.P. HD Duodenoscope (Device) $1,500
- RINVOQ (Biological) $1,368
- STELARA (Biological) $1,297
- HUMIRA (Biological) $973.95
- DUPIXENT (Biological) $951.06
- XIFAXAN (Drug) $864.17
- ZENPEP (Drug) $539.00
- ENTYVIO (Biological) $515.56
- ZEPOSIA (Drug) $482.43
- Humira (Biological) $415.56
- LINZESS (Drug) $391.02
- XELJANZ (Drug) $321.84
- Amitiza (Drug) $286.16
- VOWST (Biological) $254.37
- Epclusa (Drug) $242.08
- Cook Medical Biliary (Device) $238.82
- Entyvio (Biological) $237.47
- OCALIVA (Drug) $205.87
- INTERSTIM (Device) $169.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Irvine
Dr. Tung Ngo, Do, DO
Internal Medicine — Payments: $4.9M
Internal Medicine $4.9M
Rashmi Kumar, Md, MD
Internal Medicine — Payments: $121,958
Internal Medicine $121,958
Dr. Irene Kang, M.d, M.D
Internal Medicine — Payments: $55,000
Internal Medicine $55,000
Dr. Behdad Akbarpour, Md, MD
Internal Medicine — Payments: $34,097
Internal Medicine $34,097
Dr. Maher Kassis, M.d, M.D
Internal Medicine — Payments: $30,310
Internal Medicine $30,310
Dr. Shanta Chawla, Md, MD
Internal Medicine — Payments: $17,484
Internal Medicine $17,484